Inst Diagnosti Cash Flow Conversion Efficiency
Inst Diagnosti cash flow conversion efficiency. Based on the latest financial reports, Inst Diagnosti (INDISA) has a cash flow conversion efficiency ratio of 0.087x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CL$8.87 Billion ≈ $9.92 Million USD) by net assets (CL$102.41 Billion ≈ $114.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Inst Diagnosti (2014–2021)
Cash flow conversion efficiency of Inst Diagnosti from 2014 to 2021. This chart illustrates how Inst Diagnosti's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Inst Diagnosti for real-time trading data and today's change.
Inst Diagnosti Cash Flow Conversion Ratio Explained
Inst Diagnosti cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Inst Diagnosti Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inst Diagnosti ranked by their cash flow conversion efficiency. Also see Inst Diagnosti market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Trakcja PRKiI S.A.
WAR:TRK
|
0.206x |
|
Dasheng Times Cultural Investment Co Ltd
SHG:600892
|
-6.385x |
|
NH SPAC 8
KQ:225570
|
-0.014x |
|
Sichuan Troy Information Technology Co Ltd
SHE:300366
|
-0.022x |
|
Seoul Semiconductor Co. Ltd
KQ:046890
|
0.067x |
|
Ambac Financial Group Inc
NYSE:AMBC
|
-0.036x |
|
Shoe Carnival Inc
NASDAQ:SCVL
|
0.034x |
|
Berto Acquisition Corp. Ordinary Shares
NASDAQ:TACO
|
0.000x |
Annual Cash Flow Conversion Efficiency for Inst Diagnosti (2014–2021)
The table below shows the annual cash flow conversion efficiency of Inst Diagnosti from 2014 to 2021. Review INDISA FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2021-12-31 | CL$95.17 Billion ≈ $106.43 Million |
CL$14.83 Billion ≈ $16.59 Million |
0.156x | -8.57% |
| 2020-12-31 | CL$84.82 Billion ≈ $94.86 Million |
CL$14.46 Billion ≈ $16.17 Million |
0.170x | +30.98% |
| 2019-12-31 | CL$81.92 Billion ≈ $91.61 Million |
CL$10.66 Billion ≈ $11.92 Million |
0.130x | -32.89% |
| 2018-12-31 | CL$76.08 Billion ≈ $85.09 Million |
CL$14.75 Billion ≈ $16.50 Million |
0.194x | -10.15% |
| 2017-12-31 | CL$69.00 Billion ≈ $77.16 Million |
CL$14.89 Billion ≈ $16.65 Million |
0.216x | +17.62% |
| 2016-12-31 | CL$63.05 Billion ≈ $70.51 Million |
CL$11.57 Billion ≈ $12.94 Million |
0.183x | -30.86% |
| 2015-12-31 | CL$56.73 Billion ≈ $63.44 Million |
CL$15.05 Billion ≈ $16.84 Million |
0.265x | -2.00% |
| 2014-12-31 | CL$50.16 Billion ≈ $56.10 Million |
CL$13.58 Billion ≈ $15.19 Million |
0.271x | -- |
About Inst Diagnosti
Instituto de Diagnóstico S.A. provides health services in Chile. It offers patient information and exams instruction, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hos… Read more